Streetbeat News

Analyst Ratings

SHC

Sotera Health's stock rating has been upgraded from Sector Weight to Overweight by analysts at Keybanc, leading to higher trading.

Portfolio Pulse from Benzinga Newsdesk

June 26, 2023 | 12:19 pm

IMRX

Immuneering (NASDAQ:IMRX) has received 3 bullish, 1 somewhat bullish, and 2 indifferent analyst ratings in the last quarter. The average 12-month price target for the stock is $18.83, up 47.69% from the previous average of $12.75.

Portfolio Pulse from Benzinga Insights

June 26, 2023 | 12:02 pm

ARVN

Over the past 3 months, 8 analysts have published their opinion on Arvinas (NASDAQ:ARVN) stock, with an average price target of $70.62, implying an upside from the current price of $25.47. The current average has increased by 24.99% from the previous average price target of $56.50.

Portfolio Pulse from Benzinga Insights

June 26, 2023 | 12:02 pm

WSFS

In the last quarter, WSFS Financial (NASDAQ:WSFS) received 1 bullish, 2 somewhat bullish, and 1 indifferent analyst rating. The average 12-month price target for the stock is $46.75, up 1.63% from the previous average of $46.00.

Portfolio Pulse from Benzinga Insights

June 26, 2023 | 12:01 pm

ESPR

Over the past 3 months, 5 analysts have published their opinion on Esperion Therapeutics (NASDAQ:ESPR) stock, with an average price target of $14.0, implying significant upside from the current price of $1.33. The current average has increased by 111.48% from the previous average price target of $6.62.

Portfolio Pulse from Benzinga Insights

June 26, 2023 | 12:01 pm

UAL

Over the past 3 months, 6 analysts have published their opinion on United Airlines Holdings (NASDAQ:UAL) stock, with an average 12-month price target of $70.17, up 4.73% from the previous average of $67.00. The ratings include 1 bullish and 5 somewhat bullish opinions.

Portfolio Pulse from Benzinga Insights

June 26, 2023 | 12:01 pm

UBX

In the last quarter, Unity Biotechnology (NASDAQ:UBX) received 3 bullish, 1 somewhat bullish, and 1 indifferent analyst ratings. The average 12-month price target for the company is $6.2, with a high of $10.00 and a low of $2.00. The average price target has increased by 43.19% over the past month.

Portfolio Pulse from Benzinga Insights

June 26, 2023 | 12:00 pm

CCRN

William Blair analyst Trevor Romeo initiates coverage on Cross Country Healthcare (NASDAQ:CCRN) with an Outperform rating.

Portfolio Pulse from richadhand@benzinga.com

June 26, 2023 | 11:57 am

GRBK

B. Riley Securities analyst Alex Rygiel downgraded Green Brick Partners (NYSE:GRBK) from Buy to Neutral and announced a $62 price target.

Portfolio Pulse from richadhand@benzinga.com

June 26, 2023 | 11:55 am

INVE

B. Riley Securities analyst Craig Ellis upgraded Identiv (NASDAQ:INVE) from Neutral to Buy and raised the price target from $10 to $11.

Portfolio Pulse from richadhand@benzinga.com

June 26, 2023 | 11:53 am